Nanostructured Formulations in Skin Cancer: Challenges and Perspectives
Dr. Monti graduated in Chemistry and Pharmaceutical Technology in 1987 and received the PhD in "Design, Development and Bio-evaluation of Drugs" in 1993 and continued to work in the technological and biopharmaceutical field. In 2000, she became Assistant Professor of Pharmaceutical Technology at the Department of Pharmacy, University of Pisa. Her scientific research is oriented towards the study of drug delivery systems to the cutaneous, ungual, ocular, vaginal and buccal site, the use of cell cultures to evaluate toxicity on corneal epithelium cells of ophthalmic excipients and the cosmetic field, by focusing attention on the irritating and corrosive effect, on the one hand, and cutaneous permeation/penetration of cosmetic ingredients, on the other one. From 1997 to 2000 he participated in the European project BIOMED-2, (BMH4-97-2324) entitled "Evaluation of oculotoxicity of drugs in vitro" with the following European partners: University of Tampere (Finland), University of Bremen (Germany), University of Ioannina (Greece), Orion Corporation Ltd. and Oy Star AB, (Finland). She is also responsible for several research projects involving international companies. Furthermore, she is the author of many publications in international journals with referee, of patents and presented her research at national and international meetings. She has been reviewer for many scientific journals such as International Journal of Pharmaceutics, Journal of Controlled Release, Journal of Pharmacy and Pharmacology, European Journal of Pharmaceutical Sciences, European Journal of Pharmaceuticals and Biopharmaceutics, Pharmaceutics and AAPS PharmSciTech.